Amneal Pharmaceuticals, Inc.
✓ Verified ManufacturerAbout
Amneal Pharmaceuticals, Inc. is a leading pharmaceutical manufacturer headquartered in Bridgewater, New Jersey, dedicated to making healthy possible through innovative drug development and manufacturing excellence. The company operates a comprehensive portfolio of approximately 280 generic and specialty pharmaceuticals, serving patients across the United States, India, and Ireland. Amneal specializes in developing complex first-to-file and first-to-market medicines, with particular expertise in oncology treatments, Parkinson's disease therapies, and critical care medications including naloxone nasal spray. The company's advanced manufacturing capabilities enable production of generic pharmaceuticals, specialty products, and biosimilars across multiple therapeutic areas. With over 160 million prescription scripts filled in the United States during 2024, Amneal demonstrates significant market presence and manufacturing scale. Recent product launches include Brekiya autoinjector for migraine treatment and CREXONT for Parkinson's disease, showcasing the company's commitment to addressing unmet medical needs. The pharmaceutical manufacturer maintains robust research and development operations focused on complex drug formulations and delivery systems. Amneal's integrated approach combines innovative manufacturing processes with rigorous quality standards to deliver accessible medications to patients worldwide. The company's strategic focus on specialty pharmaceuticals, combined with its established generic drug platform, positions Amneal as a versatile pharmaceutical manufacturing partner committed to improving patient outcomes through reliable, high-quality medicines.